Analysts’ Opinions Are Mixed on These Healthcare Stocks: GW Pharma (NASDAQ: GWPH), Perrigo Company (NYSE: PRGO) and Applied Molecular Transport (NASDAQ: AMTI)

By Ryan Adsit

Analysts have been eager to weigh in on the Healthcare sector with new ratings on GW Pharma (GWPHResearch Report), Perrigo Company (PRGOResearch Report) and Applied Molecular Transport (AMTIResearch Report).

GW Pharma (GWPH)

In a report issued on February 19, Danielle Brill from Raymond James maintained a Hold rating on GW Pharma. The company’s shares closed last Friday at $213.81, close to its 52-week high of $217.50.

According to TipRanks.com, Brill is a 4-star analyst with an average return of 17.7% and a 54.8% success rate. Brill covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Sarepta Therapeutics, and SAGE Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for GW Pharma with a $217.13 average price target, which is a 1.6% upside from current levels. In a report issued on February 4, H.C. Wainwright also downgraded the stock to Hold with a $220.00 price target.

See today’s analyst top recommended stocks >>

Perrigo Company (PRGO)

In a report released yesterday, Elliot Wilbur from Raymond James maintained a Hold rating on Perrigo Company. The company’s shares closed last Friday at $42.10, close to its 52-week low of $40.01.

According to TipRanks.com, Wilbur is a 1-star analyst with an average return of -0.5% and a 47.4% success rate. Wilbur covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Amneal Pharmaceuticals, and Flexion Therapeutics.

Perrigo Company has an analyst consensus of Hold, with a price target consensus of $49.00.

Applied Molecular Transport (AMTI)

In a report released today, Joseph Schwartz from Leerink Partners maintained a Buy rating on Applied Molecular Transport, with a price target of $74.00. The company’s shares closed last Friday at $64.47, close to its 52-week high of $67.45.

According to TipRanks.com, Schwartz is a 5-star analyst with an average return of 20.5% and a 53.4% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, KalVista Pharmaceuticals, and Aurinia Pharmaceuticals.

Currently, the analyst consensus on Applied Molecular Transport is a Moderate Buy with an average price target of $74.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.